Fortis Healthcare Limited — Others, 20-05-2025: Change in Management

Fortis Healthcare has announced a board meeting during which it approved the financial results for the quarter and half-year. The board proposed a final dividend of ₹1 per equity share for 2024-25, subject to shareholder approval. It appointed M/s Neelam Gupta & Associates as Secretarial Auditors for five years and M/s Jitender, Navneet & Co. as Cost Auditor for 2025-26, pending shareholder consent. Key updates include acquiring non-controlling shares in Agilus Diagnostics via NCD issuance and ongoing cooperation with regulatory investigations related to past transactions. Legal disputes on trademarks and leases continue, with recovery efforts underway. The company remains confident these matters will not materially affect its finances.